IVA
Twin Vee Powercats, Inc.
NASDAQ · Healthcare · Biotechnology · FR
$2.98
+1.36%Next report
Analyst consensus
- Next report date
- Mar 31, 2027
- EPS estimate
- -$0.33
- Revenue estimate
- $4.7M
Latest reported
- Last report date
- Sep 28, 2026
- EPS actual
- -$0.28
- EPS estimate
- -$0.20
- Revenue actual
- —
- Revenue estimate
- $2.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -239.5%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $18
- PT range
- $14 – $21
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 28, 2026 | -$0.20 | -$0.28 | Miss -42.05% | — |
| Sep 25, 2025 | -$0.41 | -$1.89 | Miss -361.73% | $5.2M |
| May 23, 2025 | -$0.47 | -$2.69 | Miss -472.95% | $6.7M |
| Sep 25, 2024 | -$0.56 | -$1.01 | Miss -81.10% | $2.9M |
| Sep 19, 2022 | -$0.90 | -$0.75 | Beat 16.59% | $70.1K |
| Mar 3, 2022 | -$0.90 | -$0.76 | Beat 15.33% | $4.6M |
| Sep 20, 2021 | -$0.91 | -$0.46 | Beat 48.96% | $77.1K |
| Sep 16, 2020 | -$0.69 | -$0.32 | Beat 53.20% | $83.3K |
| Jun 29, 2019 | — | -$1.05 | — | $4.0M |
| Dec 31, 2018 | — | -$0.91 | — | $3.8M |
| Dec 31, 2017 | — | -$0.67 | — | $5.5M |
| Dec 31, 2016 | — | -$0.31 | — | $8.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027